Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Michele Figus, Luca Agnifili, Manuela Lanzini, Lorenza Brescia, Francesco Sartini, Leonardo Mastropasqua & Chiara Posarelli. (2021) Topical preservative-free ophthalmic treatments: an unmet clinical need. Expert Opinion on Drug Delivery 18:6, pages 655-672.
Read now
Read now
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin. (2021) The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opinion on Drug Safety 20:4, pages 453-466.
Read now
Read now
Karen Walsh & Lyndon Jones. (2019) The use of preservatives in dry eye drops. Clinical Ophthalmology 13, pages 1409-1425.
Read now
Read now
John Thygesen. (2018) Glaucoma therapy: preservative-free for all?. Clinical Ophthalmology 12, pages 707-717.
Read now
Read now
Konstadinos G. Boboridis & Anastasios G.P. Konstas. (2018) Evaluating the novel application of cyclosporine 0.1% in ocular surface disease. Expert Opinion on Pharmacotherapy 19:9, pages 1027-1039.
Read now
Read now
Gail Torkildsen, Sherryl Frisch, Mingqi Bai, Louis Gentner$suffix/text()$suffix/text(), Uday Doshi & Jane Zhang. (2016) Safety and comfort evaluation of a new formulation of Visine® lubricant eye drops containing HydroBlend™ and GentlePur™. Clinical Ophthalmology 10, pages 331-336.
Read now
Read now
Tejaswini Walimbe, Vidya Chelerkar, Purvi Bhagat, Abhijeet Joshi & Atul Raut. (2016) Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma. Clinical Ophthalmology 10, pages 821-827.
Read now
Read now
Alberto Aguayo Bonniard, Jacky Y. Yeung, Clara C. Chan & Catherine M. Birt. (2016) Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert Opinion on Drug Metabolism & Toxicology 12:11, pages 1279-1289.
Read now
Read now
Osama Saher, Dalia M. Ghorab & Nadia M. Mursi. (2016) Preparation and in vitro/in vivo evaluation of antimicrobial ocular in situ gels containing a disappearing preservative for topical treatment of bacterial conjunctivitis. Pharmaceutical Development and Technology 21:5, pages 600-610.
Read now
Read now
Anastasios G. P. Konstas & Gabor Holló. (2016) Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma. Expert Opinion on Pharmacotherapy 17:9, pages 1271-1283.
Read now
Read now
Lauren M Rosin & Nicholas P Bell. (2013) Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye drops. Clinical Ophthalmology 7, pages 2131-2135.
Read now
Read now
Marcella Nebbioso, Mariasilvia Evangelista, Aloisa Librando, Dario Di Blasio & Nicola Pescosolido. (2012) Fixed topical combinations in glaucomatous patients and ocular discomfort. Expert Opinion on Pharmacotherapy 13:13, pages 1829-1835.
Read now
Read now
Maurizio Rolando, Julie Y Crider & Malik Y Kahook. (2011) Ophthalmic preservatives: focus on polyquaternium-1. Expert Opinion on Drug Delivery 8:11, pages 1425-1438.
Read now
Read now
Daoud Al-Badriyeh, Chin Fen Neoh, Kay Stewart & David CM Kong. (2010) Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clinical Ophthalmology 4, pages 391-405.
Read now
Read now
Cristiana Valente & Michele Iester. (2010) Impact of glaucoma medication on ocular tissue. Expert Review of Ophthalmology 5:3, pages 405-412.
Read now
Read now
Indu Pal Kaur, Shruti Lal, Cheena Rana, Shilpa Kakkar & Harinder Singh. (2009) Ocular preservatives: associated risks and newer options. Cutaneous and Ocular Toxicology 28:3, pages 93-103.
Read now
Read now
Articles from other publishers (64)
Anne Hedengran Nagstrup. (2023) The use of benzalkonium chloride in topical glaucoma treatment. Acta Ophthalmologica 101:S278, pages 3-21.
Crossref
Crossref
Nathan M. Radcliffe, Manjool Shah & Thomas W. Samuelson. (2023) Challenging the "Topical Medications-First” Approach to Glaucoma: A Treatment Paradigm in Evolution. Ophthalmology and Therapy 12:6, pages 2823-2839.
Crossref
Crossref
Ahed Raad Hameed & Athmar DH. H. Al-Shohani. (2023) Preservatives in ophthalmic formulations and the urgent need for
preservative-free formulation. Bionatura 8:CSS 3, pages 1-22.
Crossref
Crossref
Anne Hedengran & Miriam Kolko. (2023) The molecular aspect of anti-glaucomatous eye drops - are we harming our patients?. Molecular Aspects of Medicine 93, pages 101195.
Crossref
Crossref
Noémie Bonneau, Anaïs Potey, Michael-Adrien Vitoux, Romain Magny, Camille Guerin, Christophe Baudouin, Jean-Michel Peyrin, Françoise Brignole-Baudouin & Annabelle Réaux-Le Goazigo. (2023) Corneal neuroepithelial compartmentalized microfluidic chip model for evaluation of toxicity-induced dry eye. The Ocular Surface 30, pages 307-319.
Crossref
Crossref
Tom Paterson, Serap Azizoglu, Moneisha Gokhale, Madeline Chambers & Cenk Suphioglu. (2023) Preserved Ophthalmic Anti-Allergy Medication in Cumulatively Increasing Risk Factors of Corneal Ectasia. Biology 12:7, pages 1036.
Crossref
Crossref
Priyanka Rathee, Renu Sehrawat, Pooja Rathee, Anurag Khatkar, Esra Küpeli Akkol, Sarita Khatkar, Neelam Redhu, Gizem Türkcanoğlu & Eduardo Sobarzo-Sánchez. (2023) Polyphenols: Natural Preservatives with Promising Applications in Food, Cosmetics and Pharma Industries; Problems and Toxicity Associated with Synthetic Preservatives; Impact of Misleading Advertisements; Recent Trends in Preservation and Legislation. Materials 16:13, pages 4793.
Crossref
Crossref
Priyanka Agarwal & Ilva D. Rupenthal. (2023) Non-aqueous formulations in topical ocular drug delivery – A paradigm shift?. Advanced Drug Delivery Reviews 198, pages 114867.
Crossref
Crossref
Maria Francesca Cordeiro, Stefano Gandolfi, Konstantin Gugleta, Eduardo M. Normando & Francesco Oddone. (2023) How latanoprost changed glaucoma management. Acta Ophthalmologica.
Crossref
Crossref
Nathan Radcliffe. (2023) The case for standalone micro-invasive glaucoma surgery: rethinking the role of surgery in the glaucoma treatment paradigm. Current Opinion in Ophthalmology 34:2, pages 138-145.
Crossref
Crossref
Charis B. Hoppe, Sean Yonamine, Brandon W. Kao, Marcus L. Turner, Yvonne Ou, Ying Han, Jeremy D. Keenan & Julius T. Oatts. (2023) Randomized Trial to Evaluate the Efficacy of the Nanodropper Device for Pupillary Dilation and Cycloplegia in Children. Ophthalmology 130:3, pages 324-330.
Crossref
Crossref
Sihem Lazreg, Rachid Garout, Fouzia Boulanab, Djalil Aberkane, Mustapha Djabour, Hakim Boudedja, Asma Acheli, Amine Derdour, Nairouz Zine El Abidine & Nadia Ghemri. (2023) Atteinte de la surface oculaire chez les patients glaucomateux : avis d’experts et algorithme de prise en charge en Algérie. Journal Français d'Ophtalmologie 46:2, pages 152-162.
Crossref
Crossref
Katarzyna Asendrych-Wicik, Jakub Zarczuk, Katarzyna Walaszek, Tomasz Ciach & Magdalena Markowicz-Piasecka. (2023) Trends in development and quality assessment of pharmaceutical formulations - F2α analogues in the glaucoma treatment. European Journal of Pharmaceutical Sciences 180, pages 106315.
Crossref
Crossref
Giulia Coco, Danilo Iannetta, Igino Febbraro, Ester Elmo & Gianluca Manni. (2022) Efficacy of Nonpreserved Sodium Hyaluronate Artificial Tears in Dry Eye Disease Patients Treated with Prostaglandin Analogs for Primary Open-Angle Glaucoma: A Prospective, Nonrandomized, Open-Label Pilot Study. Journal of Ophthalmology 2022, pages 1-8.
Crossref
Crossref
Katia Iskandar, Loïc Marchin, Laurent Kodjikian, Maxime Rocher & Christine Roques. (2022) Highlighting the Microbial Contamination of the Dropper Tip and Cap of In-Use Eye Drops, the Associated Contributory Factors, and the Risk of Infection: A Past-30-Years Literature Review. Pharmaceutics 14:10, pages 2176.
Crossref
Crossref
Ali KucukodukIrem Mukaddes DurmusMustafa AksoySerdar Karakurt. (2022) Cytotoxic, Apoptotic, and Oxidative Effects of Preserved and Preservative-Free Brimonidine in a Corneal Epithelial Cell Line. Journal of Ocular Pharmacology and Therapeutics 38:8, pages 576-583.
Crossref
Crossref
Mohd Abul Kalam, Muzaffar Iqbal, Abdullah Alshememry, Musaed Alkholief & Aws Alshamsan. (2022) Fabrication and Characterization of Tedizolid Phosphate Nanocrystals for Topical Ocular Application: Improved Solubilization and In Vitro Drug Release. Pharmaceutics 14:7, pages 1328.
Crossref
Crossref
Jeong Yeub Kim & Jae Woo Kim. (2022) Effect of the Preservative Benzalkonium Chloride in Prostaglandin Analogues on Corneal Sensitivity. Journal of the Korean Ophthalmological Society 63:3, pages 295-300.
Crossref
Crossref
Sang-Woo Park, Jiwoong Lee & Michael Kook. (2022) Efficacy, Safety and Patient-Reported Outcomes with Preservative-Free (PF) Tafluprost or PF-Dorzolamide/Timolol Compared with Preserved Latanoprost: A Prospective Multicenter Study in Korean Glaucoma Patients with Ocular Surface Disease. Pharmaceuticals 15:2, pages 201.
Crossref
Crossref
Michael H. Goldstein, Fabiana Q. Silva, Nysha Blender, Trung Tran & Srilatha Vantipalli. (2021) Ocular benzalkonium chloride exposure: problems and solutions. Eye 36:2, pages 361-368.
Crossref
Crossref
Jiwon Kim, Kyung Ehi Zoh, Hana Kim & Dong-Uk Park. (2021) A Review on the Health Risks Associated with the Use of Products Containing Benzalkonium Chloride (BKC), Focusing on Humidifier Disinfectant Products. Journal of Environmental Health Sciences 47:6, pages 513-520.
Crossref
Crossref
Lech Sedlak, Marta Świerczyńska, Weronika Borymska, Maria Zych & Dorota Wyględowska-Promieńska. (2021) Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film. BMC Ophthalmology 21:1.
Crossref
Crossref
Angela Bonaccorso, Veronica Pepe, Cristina Zappulla, Cinzia Cimino, Angelo Pricoco, Giovanni Puglisi, Francesco Giuliano, Rosario Pignatello & Claudia Carbone. (2021) Sorafenib Repurposing for Ophthalmic Delivery by Lipid Nanoparticles: A Preliminary Study. Pharmaceutics 13:11, pages 1956.
Crossref
Crossref
Omer Ersin Muz, Kenan Dagdelen, Tuncay Pirdal & Mete Guler. (2021) Comparison of BAK-preserved latanoprost and polyquad-preserved travoprost on ocular surface parameters in patients with glaucoma and ocular hypertension. International Ophthalmology 41:11, pages 3825-3835.
Crossref
Crossref
Peter W.J. Morrison & Vitaliy V. Khutoryanskiy. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery
349
375
.
D. A. Dorofeev, A. Yu. Brezhnev, I. R. Gazizova, M. A. Glasunova, E. V. Kirilik, A. V. Kuroedov, A. V. Seleznev & A. G. Shukurov. (2021) Prerequisites to Use Preservative-Free Drugs in Medication Therapy of Glaucoma. Ophthalmology in Russia 18:3, pages 532-538.
Crossref
Crossref
Yu Qian, Lu Zhang, Xinxin Gu, Lai Wei, Jialin Wang & Yihong Wang. (2021) Biological Synergy and Antimicrobial Mechanism of Hydroxypropyltrimethyl Ammonium Chloride Chitosan with Benzalkonium Chloride. Chemical and Pharmaceutical Bulletin 69:7, pages 612-619.
Crossref
Crossref
Joseph Blondeau & Heleen DeCory. (2021) In Vitro Time-Kill of Common Ocular Pathogens with Besifloxacin Alone and in Combination with Benzalkonium Chloride. Pharmaceuticals 14:6, pages 517.
Crossref
Crossref
Manuela Santonocito, Cristina Zappulla, Santa Viola, Luca Rosario La Rosa, Elena Solfato, Ilenia Abbate, Valeria Tarallo, Ivana Apicella, Chiara Bianca Maria Platania, Grazia Maugeri, Velia D’Agata, Claudio Bucolo, Sandro De Falco, Maria Grazia Mazzone & Francesco Giuliano. (2021) Assessment of a New Nanostructured Microemulsion System for Ocular Delivery of Sorafenib to Posterior Segment of the Eye. International Journal of Molecular Sciences 22:9, pages 4404.
Crossref
Crossref
Ayako Hasegawa, Melissa Gulmezian-Sefer, Ying Cheng & Ramakrishnan Srikumar. 2021. Ophthalmic Product Development. Ophthalmic Product Development
199
227
.
Anuradha Gore & Chetan Pujara. 2021. Ophthalmic Product Development. Ophthalmic Product Development
153
180
.
Ruiz Simonato Alonso, Helena Parente Solari, Eduardo de França Damasceno, Miguel Noel Nascentes BurnierJr.Jr. & Marcelo Palis Ventura. (2020) The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Pascale Dupuis, C. Lisa Prokopich, Alexander Hynes & Harold Kim. (2020) A contemporary look at allergic conjunctivitis. Allergy, Asthma & Clinical Immunology 16:1.
Crossref
Crossref
Sunu Mathew, Alon Harris, Colin M. Ridenour, Barbara M. Wirostko, Kendall M. Burgett, Molly D. Scripture & Brent Siesky. (2020) Response to: Management of Glaucoma in Pregnancy. Journal of Glaucoma 29:4, pages e27-e27.
Crossref
Crossref
Tarannum Mansoori. (2020) Management of Glaucoma in Pregnancy. Journal of Glaucoma 29:4, pages e26-e27.
Crossref
Crossref
Olga I. Aleksandrova, Igor N. Okolov, Julia I. Khorolskaya, Natalia A. Mikhailova, Diana M. Darvish & Miralda I. Blinova. 2019. Cytotoxicity - Definition, Identification, and Cytotoxic Compounds. Cytotoxicity - Definition, Identification, and Cytotoxic Compounds.
M. N. Anurova, E. O. Bakhrushina, N. B. Demina & E. S. Panteleeva. (2019) Modern Preservatives of Microbiological Stability (Review). Pharmaceutical Chemistry Journal 53:6, pages 564-571.
Crossref
Crossref
Harinder Singh Sethi, Sugourab Das, Mayuresh P. Naik & Rajshekhar Vemparala. (2018) BKC and CME: Is benzalkonium chloride hindering our efforts to achieve the desired postoperative visual acuity?. International Ophthalmology 39:9, pages 2129-2136.
Crossref
Crossref
Lemlem Tamrat, Yeshigeta Gelaw, Getenet Beyene & Addisu Gize. (2019) Microbial Contamination and Antimicrobial Resistance in Use of Ophthalmic Solutions at the Department of Ophthalmology, Jimma University Specialized Hospital, Southwest Ethiopia. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-8.
Crossref
Crossref
Daniel Tiedemann, Zaynab A. Mouhammad, Tor P. Utheim, Darlene A. Dartt, Steffen Heegaard, Goran Petrovski & Miriam Kolko. (2019) Conjunctival Goblet Cells, the Overlooked Cells in Glaucoma Treatment. Journal of Glaucoma 28:4, pages 325-333.
Crossref
Crossref
Kofi Asiedu & Sampson Listowell Abu. (2019) The impact of topical intraocular pressure lowering medications on the ocular surface of glaucoma patients: A review. Journal of Current Ophthalmology 31:1, pages 8-15.
Crossref
Crossref
Jihae ParkSoo Jin LeeKyoo Won LeeJae Chan Kim. (2019) Effect of Chronic Benzalkonium Chloride Exposure on Senescence in Trabecular Meshwork Cells. Journal of the Korean Ophthalmological Society 60:1, pages 55.
Crossref
Crossref
V. P. Erichev, S. Yu. Petrov, A. V. Volzhanin & S. A. Ghazaryan. (2019) Continuous anti-glaucoma drug therapy as a risk factor of dry eye. Vestnik oftal'mologii 135:6, pages 117.
Crossref
Crossref
Dörte von Deylen, Christina Dreher, Oliver Seidelmann & Stephan Reichl. (2018) New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations. Pharmaceutical Research 36:1.
Crossref
Crossref
David W Steven, Pouya Alaghband & Kin Sheng Lim. (2018) Preservatives in glaucoma medication. British Journal of Ophthalmology 102:11, pages 1497-1503.
Crossref
Crossref
Rachael Grundon, Emma Scurrell, John Mould, Emma Hayton-Lee & Christine Heinrich. (2018) An investigation into the bacterial contamination of goniolenses in use in clinical practice. Veterinary Ophthalmology 21:5, pages 459-463.
Crossref
Crossref
O. I. Aleksandrova, I. N. Okolov, Yu. I. Khorolskaya, I. E. Panova & M. I. Blinova. (2018) Cytotoxicity Evaluation Using in vitro System as a Criteria of Rational Choice of Tear Substitutes. Ophthalmology in Russia 15:2, pages 167-175.
Crossref
Crossref
Suzana Branković, Radica Dragojlović - Ružičić, Nataša Branković, Marija Cvetanović & Aleksandar Veselinović. (2018) BIOPTRON LIGHT THERAPY TO DRY EYE CAUSED BY LONG - TERM TOPICALLY APPLI ED ANTIGLAUCOMA DRUG WITH BENZALKONIUM - CHLORIDE. Acta Medica Medianae 57:1, pages 109-115.
Crossref
Crossref
Christian J.F. Bertens, Marlies Gijs, Frank J.H.M. van den Biggelaar & Rudy M.M.A. Nuijts. (2018) Topical drug delivery devices: A review. Experimental Eye Research 168, pages 149-160.
Crossref
Crossref
Lyndon Jones, Laura E. Downie, Donald Korb, Jose M. Benitez-del-Castillo, Reza Dana, Sophie X. Deng, Pham N. Dong, Gerd Geerling, Richard Yudi Hida, Yang Liu, Kyoung Yul Seo, Joseph Tauber, Tais H. Wakamatsu, Jianjiang Xu, James S. Wolffsohn & Jennifer P. Craig. (2017) TFOS DEWS II Management and Therapy Report. The Ocular Surface 15:3, pages 575-628.
Crossref
Crossref
Mehmet Gokhan Caglayan, Esin Kasap, Demet Cetin, Zekiye Suludere & Ugur Tamer. (2017) Fabrication of SERS active gold nanorods using benzalkonium chloride, and their application to an immunoassay for potato virus X. Microchimica Acta 184:4, pages 1059-1067.
Crossref
Crossref
Anastasios-Georgios Konstas, Konstadinos G. Boboridis, Paraskevas Kapis, Konstantinos Marinopoulos, Irini C. Voudouragkaki, Dimitrios Panayiotou, Dimitrios G. Mikropoulos, Eirini Pagkalidou, Anna-Bettina Haidich, Andreas Katsanos & Luciano Quaranta. (2016) 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy. Advances in Therapy 34:1, pages 221-235.
Crossref
Crossref
Silvia Pescina, Federica Carra, Cristina Padula, Patrizia Santi & Sara Nicoli. (2016) Effect of pH and penetration enhancers on cysteamine stability and trans-corneal transport. European Journal of Pharmaceutics and Biopharmaceutics 107, pages 171-179.
Crossref
Crossref
Jenni J. Hakkarainen, Mika Reinisalo, Symantas Ragauskas, Aila Seppänen, Simon Kaja & Giedrius Kalesnykas. (2016) Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells. International Journal of Pharmaceutics 511:1, pages 73-78.
Crossref
Crossref
Sabyasachi Maiti, Sayantan Sadhukhan & Paromita Bakshi. 2016. Nano-Biomaterials For Ophthalmic Drug Delivery. Nano-Biomaterials For Ophthalmic Drug Delivery
253
276
.
Jaclyn M. L. Chang, David J. McCanna, Lakshman N. Subbaraman & Lyndon W. Jones. (2015) Efficacy of Antimicrobials against Biofilms of Achromobacter and Pseudomonas. Optometry and Vision Science 92:4, pages 506-513.
Crossref
Crossref
Sabita M Ittoop, Leonard K Seibold & Malik Y Kahook. 2015. Glaucoma. Glaucoma
593
597
.
Peter W.J. Morrison & Vitaliy V. Khutoryanskiy. (2014) Enhancement in corneal permeability of riboflavin using calcium sequestering compounds. International Journal of Pharmaceutics 472:1-2, pages 56-64.
Crossref
Crossref
Anastasios G. P. Konstas, Irini C. Voudouragkaki, Kostantinos G. Boboridis, Anna-Bettina Haidich, Eleni Paschalinou, Theodoros Giannopoulos, Nikolaos D. Dragoumis, Alexandros K. Makridis & Malik Y. Kahook. (2014) 24-Hour Efficacy of Travoprost/Timolol BAK-Free Versus Latanoprost/Timolol Fixed Combinations in Patients Insufficiently Controlled with Latanoprost. Advances in Therapy 31:6, pages 592-603.
Crossref
Crossref
Philippe Daull, Frédéric Lallemand & Jean-Sébastien Garrigue. (2014) Benefits of cetalkonium chloride cationic oil-in-water nanoemulsions for topical ophthalmic drug delivery. Journal of Pharmacy and Pharmacology 66:4, pages 531-541.
Crossref
Crossref
Carol A. RasmussenPaul L. KaufmanJulie A. Kiland. (2014) Benzalkonium Chloride and Glaucoma. Journal of Ocular Pharmacology and Therapeutics 30:2-3, pages 163-169.
Crossref
Crossref
Michele Iester, Francesco Oddone, Paolo Fogagnolo, Paolo Frezzotti & Michele Figus. (2014) Changes in the Morphological and Functional Patterns of the Ocular Surface in Patients Treated with Prostaglandin Analogues after the Use of TSP 0.5%® Preservative-Free Eyedrops: A Prospective, Multicenter Study. Ophthalmic Research 51:3, pages 146-152.
Crossref
Crossref
Adeela Malik & Charles Claoué. (2012) Transport and interaction of cosmetic product material within the ocular surface: Beauty and the beastly symptoms of toxic tears. Contact Lens and Anterior Eye 35:6, pages 247-259.
Crossref
Crossref
Gina M. Yanochko, Su Khoh-Reiter, Mark G. Evans & Bart A. Jessen. (2010) Comparison of preservative-induced toxicity on monolayer and stratified Chang conjunctival cells. Toxicology in Vitro 24:4, pages 1324-1331.
Crossref
Crossref